Search

Olaf Schneewind Phones & Addresses

  • 5628 Blackstone Ave, Chicago, IL 60637 (773) 955-7554
  • 920 58Th St, Chicago, IL 60637
  • Burr Ridge, IL
  • 4020 Knobhill Dr, Sherman Oaks, CA 91403
  • Los Angeles, CA
  • 5628 S Blackstone Ave, Chicago, IL 60637 (773) 715-8228

Work

Company: Immunartes Dec 2017 Position: Chief marketing officer

Education

School / High School: The Rockefeller University

Emails

Industries

Higher Education

Resumes

Resumes

Olaf Schneewind Photo 1

Chief Marketing Officer

View page
Location:
Chicago, IL
Industry:
Higher Education
Work:
Immunartes
Chief Marketing Officer

University of Chicago
Louis Block Professor and Chair, Department of Microbiology

Ucla Aug 1992 - May 2001
Professor
Education:
The Rockefeller University

Publications

Us Patents

Identification Of Sortase Gene

View page
US Patent:
6773706, Aug 10, 2004
Filed:
Aug 21, 2001
Appl. No.:
09/933999
Inventors:
Olaf Schneewind - Los Angeles CA
Sarkis Mazmanian - Sherman Oaks CA
Gwen Liu - Los Angeles CA
Hung Ton-That - Los Angeles CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3900
US Classification:
4241851, 4241901, 4241921, 4241931, 4242341, 4242431, 435183, 435191, 435212, 435220, 530350
Abstract:
The present invention is a substantially purified sortase-transamidase enzyme from Gram-positive bacteria, such as. The enzyme having a molecular weight of about 23,539 or about 29,076 daltons and catalyzing a reaction that covalently cross-links the carboxyl terminus of a protein having a sorting signal to the peptidoglycan of a Gram-positive bacterium, the sorting signal having: (1) a motif of LPX X G therein; (2) a substantially hydrophobic domain of at least 31 amino acids carboxyl to the motif; and (3) a charged tail region with at least two positively charged residues carboxyl to the substantially hydrophobic domain, at least one of the two positively charged residues being arginine, the two positively charged residues being located at residues 31-33 from the motif, wherein X is any of the twenty naturally-occurring L-amino acids and X is selected from the group consisting of alanine, serine, and threonine, and wherein sorting occurs by cleavage between the fourth and fifth residues of the LPX X G motif. Variants of the enzyme, methods for cloning the gene encoding the enzyme and expressing the cloned gene, and methods of use of the enzyme, including for screening for antibiotics and for display of proteins or peptides on the surfaces of Gram-positive bacteria, are also disclosed.

Identification Of Sortase Gene

View page
US Patent:
7101692, Sep 5, 2006
Filed:
Aug 14, 2002
Appl. No.:
10/219700
Inventors:
Olaf Schneewind - Chicago IL, US
Sarkis K. Mazmanian - Brookline MA, US
Gwen Liu - Los Angeles CA, US
Hong Ton-That - Chicago IL, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12N 9/00
C12N 9/10
C12N 9/48
C07K 1/00
US Classification:
435183, 435193, 435212, 530350
Abstract:
The present invention is a substantially purified sortase-transamidase enzyme from Gram-positive bacteria, such as A specific sortase-transamidase enzyme disclosed has a molecular weight of about 29,076 daltons and catalyzes a reaction that covalently cross-links the carboxyl terminus of a protein having a sorting signal to the peptidoglycan of a Gram-positive bacterium, where the sorting signal has a a motif of NPQ/KTN/G therein. Variants of the enzyme, methods for cloning the gene encoding the enzyme and expressing the cloned gene, and methods of use of the enzyme, including for screening for antibiotics and for display of proteins or peptides on the surfaces of Gram-positive bacteria, are also disclosed.

Identification Of Sortase Gene

View page
US Patent:
7238489, Jul 3, 2007
Filed:
Oct 18, 2004
Appl. No.:
10/968317
Inventors:
Olaf Schneewind - Los Angeles CA, US
Sarkis Mazmanian - Sherman Oaks CA, US
Gwen Liu - Los Angeles CA, US
Hung Ton-That - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present invention is a substantially purified sortase-transamidase enzyme from Gram-positive bacteria, such as. The enzyme having a molecular weight of about 23,539 daltons and catalyzing a reaction that covalently cross-links the carboxyl terminus of a protein having a sorting signal to the peptidoglycan of a Gram-positive bacterium, the sorting signal having: (1) a motif of LPXXG (SEQ ID NO: 37) therein; (2) a substantially hydrophobic domain of at least 31 amino acids carboxyl to the motif; and (3) a charged tail region with at least two positively charged residues carboxyl to the substantially hydrophobic domain, at least one of the two positively charged residues being arginine, the two positively charged residues being located at residues 31-33 from the motif, wherein Xis any of the twenty naturally-occurring L-amino acids and Xis selected from the group consisting of alanine, serine, and threonine, and wherein sorting occurs by cleavage between the fourth and fifth residues of the LPXXG (SEQ ID NO: 37) motif. Variants of the enzyme, methods for cloning the gene encoding the enzyme and expressing the cloned gene, and methods of use of the enzyme, including for screening for antibiotics and for display of proteins or peptides on the surfaces of Gram-positive bacteria, are also disclosed.

Methods And Compositions Involving Lcrv Proteins

View page
US Patent:
7875280, Jan 25, 2011
Filed:
Dec 2, 2005
Appl. No.:
11/293024
Inventors:
Olaf Schneewind - Chicago IL, US
Deborah M. Anderson - Naperville IL, US
Robert Brubaker - Colombus NC, US
Kristin L. DeBord - Washington DC, US
R. William DePaolo - Chicago IL, US
Katie A. Overheim - Chicago IL, US
Elizabeth M. Morrin - Chicago IL, US
Bana Jabri - Chicago IL, US
Assignee:
The University of Chicago - Chicago IL
Michigan State University - East Lansing MI
International Classification:
A61K 39/02
C07H 21/00
US Classification:
4242341, 536 237
Abstract:
The present invention concerns methods and compositions involving modified LcrV proteins from bacteria. These methods and compositions can be employed to invoke an immune response in a subject against the bacteria, while not suppressing the immune system as much as the native LcrV protein. In certain embodiments, the present invention relates to vaccines, as well as methods to protect a subject against and plague. Moreover, the present invention concerns methods and compositions for suppressing a subject's immune system using non-native LcrV polypeptides.

Methods And Compositions Involving Sortase B

View page
US Patent:
20060073530, Apr 6, 2006
Filed:
Aug 15, 2002
Appl. No.:
10/219783
Inventors:
Olaf Schneewind - Chicago IL, US
Sarkis Mazmanian - Brookline MA, US
Kenneth Su - Irvine CA, US
Hung Ton-That - Chicago IL, US
International Classification:
G01N 33/554
C12N 9/10
G01N 33/569
US Classification:
435007320, 435193000
Abstract:
The present invention provides methods and compositions involving sortase-transamidases, including sortase B, and polypeptides that include a signal sorting sequence of NPQ/KTN/G. Methods of screening for inhibitors of Gram-positive bacteria as well as therapeutic, preventative, and research methods focusing on Gram-positive bacteria are also provided.

Gram Positive Bacterial Mutants And Methods Of Generating And Using Such Mutants

View page
US Patent:
20060275905, Dec 7, 2006
Filed:
Jul 25, 2005
Appl. No.:
11/189065
Inventors:
Taeok Bae - Chicago IL, US
Fredrik Aslund - Rijswijk, NL
Olaf Schneewind - Chicago IL, US
Dominique Missiakas - Chicago IL, US
International Classification:
A61K 49/00
C12N 15/74
C12N 1/21
US Classification:
435473000, 435252300, 424009200
Abstract:
The present invention concerns gram positive bacterial mutants, particularly mutants of the Newman strain. It also involves transposable elements that can be used to generate these mutants, as well as methods of creating such mutants with these elements. The inventions also includes methods of using the bacterial mutants to screen for different types of genes, including virulence genes, which can lead to assays for drug compounds useful in the treatment of bacterial infection.

Compositions And Methods Related To Staphylococcal Bacterium Proteins

View page
US Patent:
20090317421, Dec 24, 2009
Filed:
Jan 18, 2007
Appl. No.:
12/161315
Inventors:
Dominique Missiakas - Chicago IL, US
Yukiko Stranger-Jones - Vancouver, CA
Monica Burts - Alexandria VA, US
Olaf Schneewind - Chicago IL, US
International Classification:
A61K 39/02
US Classification:
4241901
Abstract:
The present invention concerns methods and compositions for treating or preventing a bacterial infection, particularly infection by a bacteria. The invention provides methods and compositions for stimulating an immune response against the bacteria. In certain embodiments, the methods and compositions involve a secreted virulence factor, which may be EsxA and/or EsxB, and/or peptide processed by sortase, which may be SdrD, SdrE, IsdA, IsdB SdrC, Spa, IsdC, CIfA, CIfB, SasF, or combinations thereof.

Methods And Compositions Related To Immunizing Against Staphylococcal Lung Diseases And Conditions

View page
US Patent:
20110027265, Feb 3, 2011
Filed:
Aug 29, 2008
Appl. No.:
12/675597
Inventors:
Juliane Bubeck-Wardenburg - Frankfort IL, US
Olaf Schneewind - Chicago IL, US
Brook Ragle - Chicago IL, US
Assignee:
The University of Chicago - Chicago IL
International Classification:
A61K 39/40
A61K 39/085
A61P 31/04
A61P 37/04
US Classification:
4241331, 4242371, 42419711, 4241651, 4241501
Abstract:
Embodiments of the invention include methods and compositions useful in a vaccination strategy capable of neutralizing HIa to provide immunoprotection against pneumonia. In certain aspects the invention includes a HIa with reduced toxicity, represented by a recombinant mutant form of HIa (HlaH35L) in which histidine 35 is converted to leucine, which can be used to abrogate the productive assembly of the toxin and protect a subject from staphylococcal pneumonia.
Olaf O Schneewind from Chicago, IL, age ~63 Get Report